Presentation TCT 2025 TCT 167: The predictive value of complement C1q/tumor necrosis factor-related protein 9 in combination with aortic valve calcification in coronary artery calcification Presenter: Manish Narang October 28, 2025
Presentation TCT 2025 TCT 1791: Peri-Procedural VV-ECMO Support to Facilitate Endotracheal Tumor Debulking Presenter: Brandon Ben Ge October 26, 2025
Presentation TCT 2024 TCT 840: Outcomes of Transcatheter Aortic Valve Replacement in the Population With Solid Tumors Presenter: Junaid Mir October 29, 2024
Presentation TCT 2024 TCT 1326: Tumor or Thrombus? Catheter Directed Thrombectomy of an Atypical Filling Defect Presenter: Kirpal Kochar October 28, 2024
Presentation NY Valves 2024 THROMBUS, Tumor : Use of Angiovac in a RA Mass Presenter: Vijayadithyan Jaganathan June 06, 2024
Presentation TCT 2023 TCT 947: Percutaneous Mechanical Aspiration of a Large Metastatic Cardiac Tumor Presenter: Raed Qarajeh October 25, 2023
Presentation TCT 2023 TCT 946: Mechanical Thrombectomy of a Cavoatrial Tumor Thrombi Using the AlphaVac System in Renal Cell Carcinoma Presenter: Akruti Prabhakar October 25, 2023
Presentation CTO 2023 Effect of Percutaneous Coronary Intervention on Reduce Metalloproteinase 9 (MMP-9), Soluble Suppression of Tumorigenicity 2 (sST2), N Terminal Pro B-Type Natriuretic Peptides (NT Pro BNP) and Anginal Component in Quality of Life of Chronic Total… Presenter: I Made Junior Rina Artha February 23, 2023
Presentation TCT 2020 TCT 562: Left Ventricular Tumors, Is AngioVac a Feasible Option? Presenter: Aman Gupta October 14, 2020
Presentation TCT 2013 Appropriate Tumors, Stages and Locations, Relevant Vascular Anatomy, and Clinical Goals and Expectations Presenter: Shaun Samuels October 28, 2013
Presentation Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After TAVI Presenter: O. Husser May 29, 2013